© 2000 European Society of Cardiology
Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/deletion polymorphism and left ventricular function
Regional Cardiothoracic Centre, Victoria Hospital Blackpool, UK
* Corresponding author. 1 Hillside Avenue, Blackrod, Bolton, BL6 5BS, UK. Tel.: +44-1204-699745; fax: +44-1204-699745. E-mail address: gershan{at}hotmail.com (G.K. Davis).
 |
Abstract |
|---|
Aims: We investigated the effect of the angiotensin converting enzyme (ACE) I/D polymorphism and left ventricular (LV) function on ACE gene expression in tru-cut LV myocardial biopsies from 50 consecutive patients (II: 18, ID: 18, DD: 14; 40 males) with ischaemic heart disease undergoing coronary artery bypass grafting (CABG).
Methods: The polymerase chain reaction was used for ACE genotyping. LV function [normal (n = 22) or impaired] was determined by left ventriculography at cardiac catheterisation prior to bypass surgery. ACE expression was determined (n = 46) by a competitive quantitative reverse transcription PCR assay using 5x105, 12.5x105 and 20x105 copies of a mutant DNA internal standard (IS). PCR products were analysed by negative film photography and laser densitometry to determine the number of ACE transcripts present.
Results: Mean age was similar (II: 59.1±10.4, ID: 57.0±10.6, DD: 61.4±6.2; P = NS) with no differences between groups in sex (P = 0.25); hypertension, P = 0.31; previous myocardial infarction, P = 0.44; LV function, P = 0.23; and ACE inhibitor therapy, P = 0.06. ACE expression per 100 ng of total RNA varied with genotype [< 5x105 copies in II: 6, 5–12.5x105 copies in II: 6, ID: 16, DD: 4; and >12.5x105 (II: 4, ID: 2, DD: 8), Kendall's tau-b coefficient (
b) = 0.43, P = 0.003]. Impaired LV function also correlated with higher levels of ACE expression, Kendall's b = 0.40, P = 0.001.
Conclusion: ACE gene expression in the left ventricle varied with ACE genotype and LV function in IHD patients undergoing CABG.
Key Words: Angiotensin converting enzyme • Myocardium • Gene polymorphism
Received October 19, 1999; Revised February 23, 2000; Accepted March 6, 2000
1 Current address: Interventional Cardiology, 5th Floor, Green Lane Hospital, Green Lane West, Auckland, New Zealand. e-mail: gershand{at}ahsl.co.nz
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. A Voors, P. P van Geel, M. Oosterga, H. Buikema, D. J van Veldhuisen, and W. H van Gilst Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 130 - 134. [Abstract] [PDF]
|
|
|
|
 |
|
 B. R. Palmer, A. P. Pilbrow, T. G. Yandle, C. M. Frampton, A. M. Richards, M. G. Nicholls, and V. A. Cameron Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction J. Am. Coll. Cardiol., March 5, 2003; 41(5): 729 - 736. [Abstract] [Full Text] [PDF]
|
|